Liberia vs Sierra Leone: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Liberia
0.7%
in 2024
Sierra Leone
0.7%
in 2024
Liberia rank
43rd
Sierra Leone rank
43rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Liberia
- Sierra Leone
How they compare
Liberia currently reports 0.7% against 0.7% in Sierra Leone, a difference of 0.0%.
Across all 10 years both countries report, Sierra Leone has been ahead every year.
Liberia ranks 43rd and Sierra Leone ranks 43rd of 215 countries.
Sierra Leone has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.3% | 0.1% | Sierra Leone |
| 2020s | 0.7% | 0.8% | 0.1% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Liberia or Sierra Leone?
- Liberia, at 0.7% against 0.7% in Sierra Leone as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Liberia and Sierra Leone?
- 0.0%, with Liberia ahead.
- How many years of comparable data are there for Liberia and Sierra Leone?
- 10 years are reported by both, from 2015 to 2024.
- How do Liberia and Sierra Leone rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Liberia ranks 43rd and Sierra Leone ranks 43rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.